Co-Diagnostics Enters Material Definitive Agreement
Ticker: CODX · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1692415
| Field | Detail |
|---|---|
| Company | Co-Diagnostics, Inc. (CODX) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
Related Tickers: CDXC
TL;DR
CDXC signed a big deal, filing shows. Big news incoming.
AI Summary
Co-Diagnostics, Inc. announced on April 25, 2025, that it has entered into a material definitive agreement. The company, incorporated in Utah with its principal executive offices in Salt Lake City, filed this current report on Form 8-K.
Why It Matters
This filing indicates a significant new contract or partnership for Co-Diagnostics, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks related to contract fulfillment, financial obligations, or strategic alignment.
Key Numbers
- 001-38148 — SEC File Number (Identifies Co-Diagnostics, Inc.'s filing with the SEC)
- 46-2609363 — IRS Employer Identification Number (Tax identification number for Co-Diagnostics, Inc.)
Key Players & Entities
- Co-Diagnostics, Inc. (company) — Filer of the 8-K report
- April 25, 2025 (date) — Date of the earliest event reported
- 4049 SOUTH HIGHLAND DRIVE (address) — Business and mailing address of Co-Diagnostics, Inc.
- SALT LAKE CITY (location) — City of Co-Diagnostics, Inc. principal executive offices
- UT (location) — State of incorporation and principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Co-Diagnostics, Inc. on April 25, 2025?
The filing states that Co-Diagnostics, Inc. entered into a material definitive agreement on April 25, 2025, but the specific details of this agreement are not provided in the excerpt.
What is the principal business of Co-Diagnostics, Inc.?
Co-Diagnostics, Inc. is in the business of Surgical & Medical Instruments & Apparatus, as indicated by its SIC code [3841].
Where are Co-Diagnostics, Inc.'s principal executive offices located?
The principal executive offices of Co-Diagnostics, Inc. are located at 2401 S. Foothill Drive, Suite D, Salt Lake City, Utah 84109.
What is the fiscal year end for Co-Diagnostics, Inc.?
The fiscal year end for Co-Diagnostics, Inc. is December 31 (1231).
What is the filing date of this Form 8-K?
This Form 8-K was filed as of April 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Co-Diagnostics, Inc. (CODX).